A feasible shortcut for the mobilization outcome: Steady state CD34 positive hematopoietic stem cells

Transfusion and Apheresis Science

Volumn 47, Issue 1, 2012, Pages 67-75

  Yüksel, Meltem Kurt ^a   Tekgündüz, Emre ^a   Sönmez, Çigdem ^a   Topcuoglu, Pervin ^b   Yurtcu, Arzu ^a   Demiriz, Itir ^a   Tetik, Ayşegül ^a   Kayikçi, Ömür ^a   Cinarsoy, Murat ^a   Altuntaş, Fevzi ^a  

^a Ankara Oncology Research and Education Hospital   (Turkey)

^b ANKARA UNIVERSITY   (Turkey)

Author keywords

Lymphoma; Mobilization; Multiple myeloma; Steady state CD34; Stem cell

Indexed keywords

RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR;

ADULT; AGED; APHERESIS; ARTICLE; CD34 SELECTION; CELL COUNT; COST EFFECTIVENESS ANALYSIS; DRUG COST; FEMALE; HEMATOPOIETIC STEM CELL; HUMAN; HUMAN CELL; LYMPHOMA; MAJOR CLINICAL STUDY; MALE; MYELOMA; STEADY STATE; STEM CELL MOBILIZATION;

ADOLESCENT; ADULT; AGED; FEMALE; HEMATOPOIETIC STEM CELL MOBILIZATION; HEMATOPOIETIC STEM CELLS; HUMANS; LEUKOCYTE COUNT; LYMPHOMA; MALE; MIDDLE AGED; MULTIPLE MYELOMA; PERIPHERAL BLOOD STEM CELL TRANSPLANTATION; TRANSPLANTATION, AUTOLOGOUS;

EID: 84862890429     PISSN: 14730502     EISSN: 18781683     Source Type: Journal    
DOI: 10.1016/j.transci.2012.05.003     Document Type: Article

References (28)

1. Krause D.S., Fackler M.J., Civin C.I., May W.S. CD34: structure, biology, and clinical utility. Blood 1996, 87(1):1-13.
2. Sutherland D.R., Keating A., Nayar R., Anania S., Stewart A.K. Sensitive detection and enumeration of CD34+ cells in peripheral and cord blood by flow cytometry. Exp Hematol 1994, 22(10):1003-1010.
3. Pettengell R., Testa N.G., Swindell R., Crowther D., Dexter T.M. Transplantation potential of hematopoietic cells released into the circulation during routine chemotherapy for non-Hodgkin's lymphoma. Blood 1993, 82(7):2239-2248.
4. Kessinger A., Armitage J.O., Landmark J.D., Weisenburger D.D. Reconstitution of human hematopoietic function with autologous cryopreserved circulating stem cells. Exp Hematol 1986, 14(3):192-196.
5. Kessinger A., Armitage J.O., Landmark J.D., Smith D.M., Weisenburger D.D. Autologous peripheral hematopoietic stem cell transplantation restores hematopoietic function following marrow ablative therapy. Blood 1988, 71(3):723-727.
6. Gianni A.M., Siena S., Bregni M., Tarella C., Stern A.C., Pileri A., et al. Granulocyte-macrophage colony-stimulating factor to harvest circulating haemopoietic stem cells for autotransplantation. Lancet 1989, 2(8663):580-585.
7. Anderlini P., Przepiorka D., Seong C., Smith T.L., Huh Y.O., Lauppe J., et al. Factors affecting mobilization of CD34+ cells in normal donors treated with filgrastim. Transfusion 1997, 37(5):507-512.
8. Kuittinen T., Nousiainen T., Halonen P., Mahlamäki E., Jantunen E. Prediction of mobilisation failure in patients with non-Hodgkin's lymphoma. Bone Marrow Transplant 2004, 33(9):907-912.
9. Demirer T., Buckner C.D., Gooley T., Appelbaum F.R., Rowley S., Chauncey T., et al. Factors influencing collection of peripheral blood stem cells in patients with multiple myeloma. Bone Marrow Transplant 1996, 17(6):937-941.
10. Perea G., Sureda A., Martino R., Altés A., Martínez C., Cabezudo E., et al. Predictive factors for a successful mobilization of peripheral blood CD34+ cells in multiple myeloma. Ann Hematol 2001, 80(10):592-597.
11. Gidron A., Singh V., Egan K., Mehta J. Significance of low peripheral blood CD34+ cell numbers prior to leukapheresis: what should the threshold required for apheresis be?. Bone Marrow Transplant 2008, 42(7):439-442. [Epub 2008 Jul 7].
12. Fu P., Bagai R.K., Meyerson H., Kane D., Fox R.M., Creger R.J., et al. Pre-mobilization therapy blood CD34+ cell count predicts the likelihood of successful hematopoietic stem cell mobilization. Bone Marrow Transplant 2006, 38(3):189-196.
13. de La Rubia J., Díaz M.A., Verdeguer A., Pascual M.J., Arbona C., Arrieta R., et al. Donor age-related differences in PBPC mobilization with rHuG-CSF. Transfusion 2001, 41(2):201-205.
14. Anderlini P., Przepiorka D., Seong C., Smith T.L., Huh Y.O., Lauppe J., et al. Factors affecting mobilization of CD34+ cells in normal donors treated with filgrastim. Transfusion 1997, 37(5):507-512.
15. Mikirova N.A., Casciari J.J., Hunninghake R.E., Beezley M.M. Effect of weight reduction on cardiovascular risk factors and CD34-positive cells in circulation. Int J Med Sci 2011, 8(6):445-452.
16. Egan K., Singh V., Gidron A., Mehta J. Correlation between serum lactate dehydrogenase and stem cell mobilization. Bone Marrow Transplant 2007, 40(10):931-934.
17. Szwajcer D., Jennings-Coutts A., Giftakis A., Wall D.A. Identification of the CD34 enumeration on the day before stem cell harvest that best predicts poor mobilization. Transfusion 2011, 51(3):587-590. [Epub 2010 Sep 28]. 10.1111/j.1537-2995.2010.02891.x.
18. 18 Roncon S., Barbosa I.L., Campilho F., Lopes S.M., Campos A., Carvalhais A. Mobilization and collection of peripheral blood stem cells in multiple myeloma patients older than 65years. Transplant Proc 2011, 43(1):244-246.
19. Szwajcer D., Jennings-Coutts A., Giftakis A., Wall D.A. Identification of the CD34 enumeration on the day before stem cell harvest that best predicts poor mobilization. Transfusion 2011, 51(3):587-590.
20. Fu S., Liesveld J. Mobilization of hematopoietic stem cells. Blood Rev 2000, 14(4):205-218.
21. Corso A., Varettoni M., Mangiacavalli S., Zappasodi P., Klersy C., Rusconi C., et al. Bone marrow CD34+ cell count is predictive for adequate peripheral progenitor cell collection. Leuk Res 2005, 29(2):159-163.
22. Raschle J., Ratschiller D., Mans S., Mueller B.U., Pabst T. High levels of circulating CD34+ cells at autologous stem cell collection are associated with favourable prognosis in multiple myeloma. Br J Cancer 2011, 105:970-974.
23. 3 as asurrogate marker to initiate efficient autologous blood stem cell cellection. J Clin Apher 2007, 22:277-282.
24. Kuittinen T., Nousiainen T., Halonen P., Mahlamäki E., Jantunen E. Prediction of mobilisation failure in patients with non-Hodgkin's lymphoma. Bone Marrow Transplant 2004, 33(9):907-912.
25. Stiff P.J. Management strategies for the hard-to-mobilize patient. Bone Marrow Transplant 1999, 23(Suppl. 2):S29-S33. [Review].
26. Calandra G., McCarty J., McGuirk J., Tricot G., Crocker S.A., Badel K., et al. AMD3100 plus G-CSF can successfully mobilize CD34+ cells from non-Hodgkin's lymphoma, Hodgkin's disease and multiple myeloma patients previously failing mobilization with chemotherapy and/or cytokine treatment: compassionate use data. Bone Marrow Transplant 2008, 41(4):331-338.
27. Barlak A., Kadi{dotless}köylü G., Bolaman A.Z. Splenomegaly due to the use of granulocyte-colony stimulating factor. Turk J Hematol 2004, 21(2):93-96.
28. Falzetti F., Aversa F., Minelli O., Tabilio A. Spontaneous rupture of spleen during peripheral blood stem-cell mobilisation in a healthy donor. Lancet 1999, 353(9152):555-556.